Distinguishing between primary and secondary subtypes of membranous
glomerulonephritis (MGN) is critical for its clinical management. We prospectively compared …

Circulating autoantibodies to phospholipase A2 receptor (PLA2R-Ab) are detected in> 70%
of patients with primary membranous glomerulonephritis (MGN). Detection of PLA2R …

Background. The recent finding that phospholipase-A2-receptor antibodies (PLA2R-AB)
may play a role in the development of primary membranous glomerulonephritis (MGN) offers …

Summary A commercial PLA2R Ab ELISA was validated by examining its ability to
distinguish primary from secondary membranous nephropathy, correlating results with …

Membranous nephropathy (MGN) is the most common cause of the nephrotic syndrome in
adults. Most cases of MGN are primary, but secondary MGN are frequently encountered …

Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful for affirming the diagnosis of
idiopathic membranous nephropathy (IMN). Time-resolved fluoroimmunoassay (TRFIA) is …

Background: Limited published literature exists on the utility and standardization of anti-
phospholipase A2 receptor (anti-PLA2R) immunohistochemistry (IHC) for the diagnosis of …

Background: Anti-phospholipase A2 receptor antibody (PLA2R-Ab) is useful in diagnosing
idiopathic membranous nephropathy (IMN). We investigated the clinical relevance of PLA2R …

Autoantibody formation directed against phospholipase A2 receptor (PLA2R) 1 is the
underlying etiology in most cases of primary membranous glomerulopathy. This new …

Background Phospholipase A2 receptor (PLA2R) is a major target antigen in idiopathic
membranous nephropathy (MN). Anti-PLA2R antibodies are mainly of the immunoglobulin G …